Q32 Bio Inc. (QTTB)
(Delayed Data from NSDQ)
$43.68 USD
-1.07 (-2.39%)
Updated Oct 7, 2024 03:59 PM ET
After-Market: $43.46 -0.22 (-0.50%) 4:34 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (83 out of 252)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.37 | 9.99 |
Current Quarter Estimate | -1.31 | 2.88 | 63.00 |
Year Ago Quarter Estimate | -10.25 | -4.93 | 52.25 |
Next Quarter Estimate | -1.24 | 3.66 | 66.00 |
Next Year Estimate | -4.84 | 23.73 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 84.91 | 17.60 | 15.67 |
Next Year | 2.02 | 9.90 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.83 |
Price/Book (MRQ) | 15.95 | 2.03 |
Price/Cash Flow (MRFY) | NA | 16.44 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -163.24% |
Return on Equity (TTM) | -129.44% | -61.40% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.